The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in ...

Antibiotic prescribing in primary care practice for patients with COPD exacerbations is generally based on clinical features only, which are subjective and suboptimal for identifying patients who will ...

Checking your cholesterol levels can be a huge factor in preventing heart attacks, but it's not the only prevention; there is another test that can also get quick results. This test is unfamiliar to ...

A clinical decision tool can reduce antibiotic prescriptions in children with acute illness in primary care without affecting ...

Patients with COPD exacerbations are often treated with antibiotics. There are no clear biomarkers to determine which patients will benefit from these therapies, though. A management strategy using ...

Tjarda M Boere, Laura W van Buul, Rogier M Hopstaken, Maurits W van Tulder, Jos W M R Twisk, Theo J M Verheij, Cees M P M Hertogh https://www.jstor.org/stable ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a ...

New York, March 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection ...

DUBLIN--(BUSINESS WIRE)--The "C-reactive Protein Testing Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The major factors propelling ...

DUBLIN, March 11, 2020 /PRNewswire/ -- The "C-Reactive Protein Testing Market Size, Share & Trends Analysis Report by Assay Type, by Detection Range, by Disease Area (Cancer, Endometriosis, ...

The global C-reactive protein testing market revenue was around US$ 2,765.07 million in 2021 and is estimated to reach US$ 3,588.9 million by 2030, growing at a compound annual growth rate (CAGR) of 2 ...